Exceed Safety’s Post

Great time at the Amgen Ohio Ribbon Cutting this week as shown in this great video by our CEO Bob Bradway. Some highlights of the facility design and explanations of the video: 1.      Integrated facility with views across offices and manufacturing areas that enable cross functional collaboration and inclusion in our efforts to serve patients. The interaction of our critical staff on the floor with Bob Bradway across different areas in this video shows the value of design integration. 2.      FitWel Two Star certification achieved with the video highlighting natural light cascading across areas along with other employee wellness considerations. 3.      Most advanced digital facility for Amgen final drug product packaging with automated material movements by automated guided vehicles happening behind our CEO in these video clips. 4.      First Amgen fully electrified facility, which avoids Scope 1 carbon emissions and supports carbon neutrality through sourcing of renewable energy for the reduced energy footprint. 5.      Over 50% reduction in site energy intensity per drug product unit as compared to existing facilities. 6.      LEED Gold certification on-track. Full ECOS local incentives for environmental design achievement. #mycompany #innovation #sustainability

I hope you will find time to attend this session. The collective knowledge of the panel and the insight they share will help you become the expert in your organization. #WDSUS #drugsafety #advancedautomation

Join me Thursday to learn how humm can support your practice in delivering the care pets need!

Eli Lilly’s leap to #biopharma leadership: What can we learn from their journey? This recent Fortune article describes how Eli Lilly and Company has undergone a remarkable transformation, evolving from a slower-paced pharmaceutical company to a top 10 spot as one of the world’s most valuable companies. Key to this success has been groundbreaking treatments like Mounjaro for diabetes and the obesity drug Zepbound, which have significantly boosted their revenues and market value. Visionary #leadership and strategic focus of CEO David Ricks and CSO Dan Skovronsky on cutting-edge treatments and relentless pursuit of medical advancements, such as Alzheimer’s Disease and curative gene therapies, continue to set new standards in healthcare. “Now [Lilly is] thinking about playing the game differently, as well as just playing the same game better than other people.” - Mike Rea #pharmaceuticalinnovation #asymmetriclearning https://lnkd.in/ekGAD96N

We're still riding high from the incredible experience at the inaugural CERTAINTY conference! It was inspiring to see over 350 leaders from 150 drug development companies come together to exchange knowledge, tackle industry challenges, and explore strategies for successful drug development. We're excited to keep the momentum going with the launch of CERTAINTY Europe and CERTAINTY APAC this fall! Learn more and register for CERTAINTY Europe here: https://lnkd.in/ejDR83h5 Check out what all the hype is about and what you can expect at #CERTAINTY in this short recap reel. Looking forward to pushing the boundaries in drug development! #globalCertainty #CertaintyEurope #CertaintyJapan #CertaintyChina #CertaintyKorea #Certara #CERTAINTY2024 #drugdevelopment

Dr. Jörg Duschmalé, board member of Roche, with a 128-year-old family business ownership, presented at our recent High Performance Board sessions IMD. Learn more about the program here - https://bit.ly/49XnCfP As the youngest board member at Roche, one of the largest pharmaceutical companies globally, Dr. Duschmalé emphasised that the governance structure, with the founder’s family ownership, is a key success factor. In a challenging environment, such as an aging population and a growing burden of chronic diseases, family ownership allows for a longer-term approach, rather than focusing on short-term gains. “It is easy to cut R&D, but with our transgenerational view, we choose to do the right things now within the company for the future.” In response to a question on how to prepare for being a board member in family businesses, Dr. Duschmalé expressed appreciation for a less predefined process. It gave him flexibility to approach responsibilities in various ways, especially considering his background as a chemist. Without this freedom, he might have felt constrained by the family legacy. “Be honest, be humble, and be yourself.” With this philosophy, Dr. Duschmalé’s insights illuminate the essence of serving as a board member across diverse governance environments. #imdimpact #highperformanceboards #imdboardcenter #corporategovernance #familybusiness 

What a way to start the week! Presenting about Centrus and "Enhancing Translational Safety Assessment" first thing! To find out more about the webinar, or about Centrus, DM me. #translationalscience #safetyassessment #womeninstem

Directing this to the attention of #FDA #OHSU #NCCN: DPD testing - so easy, inexpensive and life-saving. Make DPD testing mandatory prior to starting #5FU and #XELODA.

Hear what draws Genentech’s Kimberly Barnholt back to DPHARM every year! “What I really appreciate about DPHARM is feeling connected to the broader ecosystem and learning about not only what’s out there, but how we can bring it back into our daily work.” Learn more about DPHARM: DPHARMconference.com #DPHARM2024 #ClinicalTrials #ClinicalInnovation #ClinicalResearch

Continuing to serve our Pharmaceutical customer base with quality and precision!